We are live on ! Find out more
FBC

Fairfield, Bush & Co Portfolio holdings

AUM $180M
1-Year Est. Return 39.51%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$341M
AUM Growth
+$128M
Cap. Flow
+$115M
Cap. Flow %
33.88%
Top 10 Hldgs %
29.13%
Holding
169
New
43
Increased
87
Reduced
30
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Consumer Staples 14.77%
3 Healthcare 14.49%
4 Financials 12.59%
5 Energy 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
26
Philip Morris
PM
$297B
$4.74M 1.39%
56,169
-953
-2% -$82K
AMGN icon
27
Amgen
AMGN
$208B
$4.67M 1.37%
39,483
+31,262
+380% +$3.62M
RTX icon
28
RTX Corp
RTX
$290B
$4.66M 1.37%
64,151
+6,330
+11% +$466K
MA icon
29
Mastercard
MA
$506B
$4.63M 1.36%
62,998
-1,196
-2% -$88.8K
PG icon
30
Procter & Gamble
PG
$336B
$4.46M 1.31%
56,813
-1,249
-2% -$101K
MMM icon
31
3M
MMM
$91.3B
$4.19M 1.23%
35,022
+26,222
+298% +$3.08M
WMT icon
32
Walmart Inc
WMT
$885B
$4.13M 1.21%
165,165
-6,303
-4% -$162K
META icon
33
Meta Platforms (Facebook)
META
$1.41T
$3.92M 1.15%
58,175
-50
-0.1% -$3.08K
SIAL
34
DELISTED
SIGMA - ALDRICH CORP
SIAL
$3.65M 1.07%
35,923
+35,015
+3,856% +$3.4M
BHP icon
35
BHP
BHP
$215B
$3.48M 1.02%
60,104
-2,376
-4% -$140K
NEOG icon
36
Neogen
NEOG
$2.63B
$3.28M 0.96%
216,152
-12,736
-6% -$189K
BIIB icon
37
Biogen
BIIB
$30.2B
$3.15M 0.93%
+10,000
New +$3.01M
GE icon
38
GE Aerospace
GE
$376B
$3.09M 0.91%
24,522
+16,054
+190% +$2.04M
RY icon
39
Royal Bank of Canada
RY
$292B
$3.07M 0.9%
42,932
+25
+0.1% +$1.7K
ESV
40
DELISTED
Ensco Rowan plc
ESV
$2.88M 0.84%
12,934
+2,714
+27% +$562K
CHD icon
41
Church & Dwight Co
CHD
$23.5B
$2.84M 0.83%
81,222
+32,990
+68% +$1.13M
SWI
42
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
$2.71M 0.8%
70,093
LH icon
43
Labcorp
LH
$25.5B
$2.66M 0.78%
30,235
-303
-1% -$26.2K
GOOG icon
44
Alphabet (Google) Class C
GOOG
$4.38T
$2.58M 0.76%
89,184
+66,499
+293% +$1.8M
BMY icon
45
Bristol-Myers Squibb
BMY
$133B
$2.2M 0.65%
45,349
+38,524
+564% +$1.9M
NVO
46
Novo Nordisk
NVO
$209B
$2.08M 0.61%
89,940
+68,150
+313% +$1.5M
T icon
47
AT&T
T
$159B
$2.03M 0.6%
76,106
+23,371
+44% +$626K
AMZN icon
48
Amazon
AMZN
$2.94T
$1.95M 0.57%
+120,000
New +$1.9M
HSY icon
49
Hershey
HSY
$35.6B
$1.95M 0.57%
+20,000
New +$1.96M
ILMN icon
50
Illumina
ILMN
$31.1B
$1.84M 0.54%
10,578
+3,906
+59% +$583K

Similar funds

Fairfield, Bush & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Fairfield, Bush & Co held 169 positions worth $341M, up 60% from $212M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Fairfield, Bush & Co deployed $115M of net new capital in Q2 2014, opening 43 new positions and adding to 87 existing holdings. Its largest new stake was Goldman Sachs: 31,382 shares worth $5.25M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was TSMC, an estimated $335K trimmed.

  • Fairfield, Bush & Co's largest Q2 2014 buy was Goldman Sachs: 31,382 shares worth $5.25M.
  • Fairfield, Bush & Co added most to International Flavors & Fragrances in Q2 2014, an estimated $17.2M increase.
  • Fairfield, Bush & Co's biggest Q2 2014 reduction was TSMC, cutting an estimated $335K.
  • Fairfield, Bush & Co fully exited Bed Bath & Beyond Inc in Q2 2014, selling an estimated $303K.
  • Fairfield, Bush & Co's ten largest holdings make up 29% of its $341M portfolio in Q2 2014.
  • Fairfield, Bush & Co opened 43 new positions and closed 3 in Q2 2014.
  • Fairfield, Bush & Co's portfolio value rose 60% quarter-over-quarter to $341M.

Based on Fairfield, Bush & Co's 13F filing for Q2 2014, filed 15 Aug 2014.